RA101495-01.203: A Phase 2 Multicenter, Open-Label, Uncontrolled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmaqcokinetics, and Pharm
Clinical Trial Grant
Awarded By
Ra Pharmaceuticals, Inc
Start Date
June 14, 2017
End Date
December 17, 2018
Awarded By
Ra Pharmaceuticals, Inc
Start Date
June 14, 2017
End Date
December 17, 2018